Evidence map›Paper›PMID 15293784›Full record

ArticleMolecular biology reports2004

Amplification and overexpression of oncogene Mdm2 and orphan receptor gene Nr1h4 in immortal PRKDC knockout cells.

Rong Ai, Ana Sandoval, David J Chen, Sandeep Burma, Paul Labhart

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rong AiTorrey Pines Institute for Molecular Studies, 3550 General Atomics Court, San Diego, CA 92121, USA.
Ana Sandoval
David J Chen
Sandeep Burma
Paul Labhart
Lawrence Berkeley National Laboratory · USTorrey Pines Institute For Molecular Studies · USGeneral Atomics (United States) · US

Funding

Roles of DNA PK in DNA Double Strand Break RepairR37CA050519 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI CHEN, DAVID J · 2003 to 2011
$3.5M
Transgenic Mouse for DNA Damage Sensing and SignalingR01CA086936 · NCI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI CHEN, DAVID J · 2002 to 2005
$1.2M
ROLES OF DNA PK IN DNA DOUBLE STRAND BREAK REPAIRR01CA050519 · NCI · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI CHEN, DAVID J · 1989 to 2001
$946k
ROLE OF DNA DEPENDENT PROTEIN KINASE IN DNA REPAIRR01GM062113 · NIGMS · TORREY PINES INST FOR MOLECULAR STUDIES · PI LABHART, PAUL · 2000 to 2002
$806k
NCI NIH HHS CA50519NCI NIH HHS CA86936NIGMS NIH HHS GM62113
6 · The paper itself

Abstract

DNA-dependent protein kinase (DNA-PK) is required for the repair of double strand DNA breaks by nonhomologous DNA end joining. The catalytic subunit of DNA-PK, PRKDC, may also be involved in repair-related or separate cell signaling pathways. To learn more about the cellular function of DNA-PK under normal physiological conditions, we identified genes that are differentially expressed between an immortalized wild-type mouse fibroblast cell line and its DNA-PK-deficient counterpart (Prkdc -/-). The proto-oncogene Mdm2 and the farnesoid X receptor gene Nrlh4 were overexpressed in the DNA-PK-deficient cell line. We show that in the DNA-PK-deficient cell line the genes for both Mdm2 and Nrlh4 are amplified to a degree that could account for most, if not all, of their increased expression. Other genes were strongly downregulated in the DNA-PK-deficient cell line, but this opposite expression pattern was not due to gene amplification in the wild-type cells. None of these genes was differentially expressed in DNA-PK-containing and DNA-PK-deficient primary mouse embryo fibroblasts. Our results suggest a model in which DNA-PK indirectly affects the cellular gene expression profile through its caretaker role and by preventing gene amplification.

Indexed as

AnimalsCell LineDNA-Activated Protein KinaseDNA-Binding ProteinsFibroblastsGene AmplificationMiceMice, KnockoutNuclear ProteinsProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-mdm2Receptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearRecombination, GeneticSequence DeletionDNA-Activated Protein KinaseDNA-Binding ProteinsMdm2 protein, mouseNuclear ProteinsPrkdc protein, mouseProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-mdm2Receptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearTranscription Factors

Identifiers

PMID15293784
OpenAlexW1982859072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.